{"product_id":"plunketts-biotech-pharmaceuticals-genetics-industry-almanac-2022-biotech-pharmaceuticals-genetics-industry-market-research-statistics-trends-and-leading-companies","title":"Plunkett's Biotech, Pharmaceuticals \u0026 Genetics Industry Almanac 2022: Biotech, Pharmaceuticals \u0026 Genetics Industry Market Research, Statistics, Trends and Leading Companies","description":"\u003cp\u003ePLUNKETT'S BIOTECH \u0026amp; GENETICS INDUSTRY ALMANAC 2022\u003c\/p\u003e\n\n\u003cp\u003eKey Findings:Plunkett Research analyzes the major trends and technologies in the global Biotech \u0026amp; Genetics sectors. In addition, Plunkett profiles hundreds of the industry’s top firms.Key Features:Industry trends analysis, market data and competitive intelligenceMarket forecasts and Industry StatisticsIndustry Associations and Professional Societies ListIn-Depth Profiles of hundreds of leading companiesIndustry GlossaryLink to our 5-minute video overview of this industryPages: 510\u003cbr\u003e\nStatistical Tables Provided: 16\u003cbr\u003e\nCompanies Profiled: 392\u003cbr\u003e\nGeographic Focus: Global\u003c\/p\u003e\n\n\u003cp\u003eA complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms.  You will gain vital insights that can help you shape your own strategy for business development, product development and investments.How is the industry evolving?How is the industry being shaped by new technologies?How is demand growing in emerging markets and mature economies?What is the size of the market now and in the future?What are the financial results of the leading companies?What are the names and titles of top executives?What are the top companies and what are their revenues?Contents, Statistics, Forecasts and Analysis Include:\u003c\/p\u003e\n\n\u003cp\u003eMajor Trends Affecting the Biotech, Pharmaceuticals \u0026amp; Genetics Industry\u003c\/p\u003e\n\n\u003cp\u003e1.\tThe State of the Biotechnology Industry Today\u003cbr\u003e\n2.\tThe Coronavirus’ Effect on the Biotech, Pharmaceuticals \u0026amp; Genetics Industry\u003cbr\u003e\n3.\tA Short History of Biotechnology\u003cbr\u003e\n4.\tFast Track Drugs Come to Market in the U.S. with FDA Cooperation\u003cbr\u003e\n5.\tEthanol Production Soared, But U.S. Federal Subsidy Expires\u003cbr\u003e\n6.\tCellulosic Ethanol Makes Slow Commercial Progress\u003cbr\u003e\n7.\tMajor Drug Companies Acquire or Partner With Smaller Biotech Firms\u003cbr\u003e\n8.\tPharmaceutical R\u0026amp;D Improves with Artificial Intelligence (AI)\u003cbr\u003e\n9.\tFrom Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development\u003cbr\u003e\n10.\tPatients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance\u003cbr\u003e\n11.\tGene Therapies Target Defective Genes\/CRISPR Advances DNA Editing\u003cbr\u003e\n12.\tVaccines \u0026amp; Viruses as Therapies\/mRNA Shows Great Promise\u003cbr\u003e\n13.\tMassive R\u0026amp;D Investment Required for Development and Approval of New Drug\/Drug Prices Soar\u003cbr\u003e\n14.\tGeneric Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues\u003cbr\u003e\n15.\tCoupons and Other Marketing Schemes Obscure the Retail Prices of Drugs in the U.S., Which Are Vastly Higher than Prices Paid in Other Nations\u003cbr\u003e\n16.\tBiotech and Orphan Drugs Create New Revenues for Drug Firms\u003cbr\u003e\n17.\tBiosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval\/Competition Will Be Fierce\u003cbr\u003e\n18.\tMarket for CBD Is on the Rise\u003cbr\u003e\n19.\tStem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape\u003cbr\u003e\n20.\tGenetically Modified (GM) Seeds and Crops Planted in Dozens of Nations\/Agribio R\u0026amp;D Investment Is High\u003cbr\u003e\n21.\tGenetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation\u003cbr\u003e\n22.\tCloning of Farm Animals\/Meat and Cheese Substitutes Created in Laboratories\/3-D Printed Food Appears\u003cbr\u003e\n23.\tSelective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds\u003cbr\u003e\n24.\tImmunotherapy and CAR-T Create Exciting New Approach to Fighting Cancers\u003cbr\u003e\n25.\tTechnology Discussion—Genes and DNA\u003cbr\u003e\n26.\tTechnology Discussion—Proteins and Proteomics\u003cbr\u003e\n27.\tTechnology Discussion—DNA Chips\u003cbr\u003e\n28.\tTechnology Discussion—SNPs (“Snips”)\u003cbr\u003e\n29.\tTechnology Discussion—Synthetic Biology\u003cbr\u003e\n30.\tTechnology Discussion—Recombinant DNA\u003cbr\u003e\n31.\tTechnology Discussion—Polymerase Chain Reaction (PCR)\u003c\/p\u003e\n\n\u003cp\u003eBiotech, Pharmaceuticals \u0026amp; Genetics Industry Statistics\u003c\/p\u003e\n\n\u003cp\u003e1.\tBiotech Industry Statistics and Market Size Overview\u003cbr\u003e\n2.\tThe U.S. Drug Discovery \u0026amp; Approval Process\u003cbr\u003e\n3.\tU.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2020\u003cbr\u003e\n4.\tU.S. Pharmaceutical R\u0026amp;D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1994-2020\u003cbr\u003e\n5.\tEmployment in Life \u0026amp; Physical Science Occupations by Business Type, U.S.: May 2020\u003cbr\u003e\n6.\tFederal R\u0026amp;D \u0026amp; R\u0026amp;D Plant Funding for Basic Research, U.S.: Fiscal Years 2020-2022\u003cbr\u003e\n7.\tU.S. Exports \u0026amp; Imports of Pharmaceutical Products: 2015-1st Quarter 2021\u003cbr\u003e\n8.\tU.S. Prescription Drug Expenditures, Aggregate \u0026amp; Per Capita Amounts, Percent Distribution: 2012-2028\u003cbr\u003e\n9.\tPrescription Drug Expenditures, U.S.: Selected Years, 1985-2028\u003cbr\u003e\n10.\tNSF Budget by Appropriation (Dollars in Millions), Fiscal Years 2020-2022\u003cbr\u003e\n11.\tGlobal Area of Biotech Crops by Country: 2019\u003cbr\u003e\n12.\tDomestic \u0026amp; Foreign Pharmaceutical Sales, PhRMA Member Companies: 1990-2020\u003cbr\u003e\n13.\tDomestic U.S. Biopharmaceutical R\u0026amp;D \u0026amp; R\u0026amp;D Abroad, PhRMA Member Companies: 1990-2020\u003cbr\u003e\n14.\tDomestic U.S. Biopharmaceutical R\u0026amp;D \u0026amp; R\u0026amp;D Abroad Breakdown, PhRMA Member Companies: 2020\"\u003c\/p\u003e","brand":"Marketing \u0026 Market Research","offers":[{"title":"August, 2021 \/ 507 Pages \/ MCW16260706","offer_id":47697680105778,"sku":null,"price":456.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/plunketts-biotech-pharmaceuticals-genetics-industry-almanac-2022-biotech-pharmaceuticals-genetics-industry-market-research-statistics-trends-and-leading-companies","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}